Delivery Order SPE2DB22D1106-SPE2DB23FEEY4
Award Date 4/25/23
Potential Completion Date 4/26/23
Potential Value $8.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 300 mg (100 mg x 3 syringes) medical supplies. The contract has a ceiling value of $9,219.39 and a completion date of January 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,860.38, is a delivery order for the pharmaceutical product Emgality 300 mg (100 mg x 3 syr) ml. The contract has a firm fixed price and an ultimate completion date of December 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,183.17 firm fixed-price delivery order is for the supply of Emgality 300 mg (100 mg x 3 syringes) medication, with a completion date of January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 300 mg (100 mg x 3 syringes) medication. It is a firm fixed-price, non-set-aside contract with a ceiling value of $5,717.21 and a performance period through May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, worth $3,094.00, is a delivery order for the medication Emgality 300 mg. It is a firm fixed-price contract with an ultimate completion date of April 8, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor, and there is no information...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,377.66, is for the delivery of the prescription drug Emgality 120 mg/ml penml. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,754.24 firm fixed price contract is for the supply of Emgality 300 mg (100 mg x 3 syringes) medication. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a wide range of pharmaceutical and medical products to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,291.13, is for the supply of the prescription medication Emgality 120 mg/ml. The contract has an ultimate completion date of April 21, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 300 mg (100 mg x 3 syringes) medication. The contract has a ceiling value of $3,186.38 and a period of performance through October 22, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 300 mg (100 mg x 3 syringes) medication. The contract, with a ceiling value of $1,495.32, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of July 18, 2024. It is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEEY4Delivery Order
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Emgality 300 mg (100 mg x 3 syringes) medical products. The $8,917.97 firm fixed price delivery order has an ultimate completion date of April 26, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Generated 5/9/25, 10:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 4/25/23 |